In this current study we analyzed the response of colon cancer cells to hypoxia and serum depletion, the consequential conditions occurred after antiangiogenesis, irradiation and chemotherapy [11], [12], and discovered the CD133+ TICs were resistant to hypoxia and serum depletion. This evidence concerns the gene PROM1 and colonic neoplasm.